DMH Release CMHC Nasal Spray

Medline Industries, Inc. has been awarded a Release Competitive Sealed Bidding contract (24-416CMS-BOSS4-P-54128) by the Mental Health organization in Illinois, with a contract period from August 25, 2025, to June 30, 2026. The contract, valued at two hundred fifteen dollars, focuses on the procurement of medical supplies, specifically Naloxone HCL Nasal Spray, a medication used for emergency opioid overdose reversal.

The line item details indicate the contract covers a single product: Naloxone HCL Nasal Spray, single dose, over-the-counter (OTC), with a concentration of 4mg/0.1 mL, packaged in boxes of two, with a quantity of four boxes. The contract falls under the Medical Supplies category, encompassing hospital and surgical equipment, instruments, and supplies. While the specific use is not explicitly stated, the Naloxone product suggests the contract is likely intended to support emergency medical response and overdose prevention efforts within the Illinois Mental Health system.